Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stronger chemo may help avoid surgery in rectal cancer trial

NCT ID NCT07472868

First seen Mar 23, 2026 · Last updated May 23, 2026 · Updated 14 times

Summary

This study tests if a stronger chemotherapy combination (FOLFOXIRI) before standard chemoradiation leads to better tumor disappearance and quality of life compared to a standard combination (CAPOX/FOLFOX) in people with high-risk locally advanced rectal cancer. About 394 participants will receive one of the two chemo regimens, followed by radiation and possibly surgery or a watch-and-wait approach. The goal is to see if the stronger chemo increases the chance of avoiding surgery while keeping the cancer under control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Catharina Hospital Eindhoven

    Eindhoven, North Brabant, 5623 EJ, Netherlands

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.